Viking Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.5M Buy
443,000
+70,000
+19% +$4.02M 2.29% 7
2026
Q1
$22.6M Buy
373,000
+52,000
+16% +$3.03M 2.32% 7
2025
Q4
$17.3M Hold
321,000
2.01% 8
2025
Q3
$14.5M Buy
321,000
+2,300
+0.7% +$107K 1.75% 11
2025
Q2
$14.8M Hold
318,700
2.03% 6
2025
Q1
$19.4M Buy
318,700
+100,000
+46% +$5.83M 2.8% 4
2024
Q4
$12.4M Buy
218,700
+125,100
+134% +$6.99M 1.93% 7
2024
Q3
$4.84M Sell
93,600
-19,100
-17% -$896K 0.79% 49
2024
Q2
$4.68M Buy
112,700
+10,000
+10% +$447K 0.84% 45
2024
Q1
$5.57M Buy
102,700
+2,700
+3% +$138K 1.01% 32
2023
Q4
$5.13M Buy
100,000
+12,000
+14% +$630K 1% 35
2023
Q3
$5.11M Buy
88,000
+10,000
+13% +$613K 1.03% 37
2023
Q2
$4.99M Buy
78,000
+5,000
+7% +$335K 0.94% 43
2023
Q1
$5.06M Buy
73,000
+33,000
+83% +$2.33M 0.97% 36
2022
Q4
$2.88M Buy
+40,000
New +$3.02M 0.57% 66
2021
Q1
Sell
-5,000
Closed -$310K 122
2020
Q4
$310K Sell
5,000
-35,000
-88% -$2.15M 0.1% 111
2020
Q3
$2.41M Sell
40,000
-25,000
-38% -$1.5M 0.9% 38
2020
Q2
$3.82M Buy
65,000
+13,000
+25% +$778K 1.41% 24
2020
Q1
$2.9M Buy
52,000
+7,000
+16% +$428K 1.27% 30
2019
Q4
$2.89M Buy
45,000
+13,000
+41% +$745K 0.81% 47
2019
Q3
$1.62M Buy
+32,000
New +$1.5M 0.46% 64

Other funds holding BMY

Viking Fund Management's BMY Position: Q2 2026 in Review

Viking Fund Management increased its Bristol-Myers Squibb (BMY) stake by 19% in Q2 2026, buying an estimated $4.02M and bringing the position to 443,000 shares worth $25.5M. The position accounts for 2.29% of the portfolio, ranked #7.

Viking Fund Management first reported a position in BMY in Q3 2019 and has held it in 21 quarters since. 500 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Viking Fund Management held 443,000 shares of Bristol-Myers Squibb worth $25.5M as of Q2 2026.
  • Viking Fund Management bought 70,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.02M.
  • Bristol-Myers Squibb made up 2.29% of Viking Fund Management's portfolio in Q2 2026, its #7 holding.
  • Viking Fund Management first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 21 quarters since.
  • 500 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Viking Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.